Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP650186.RAikc1HGWlahgNbrjh1hzVBCNHjyDuehhOw42HRXxvL4E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650186.RAikc1HGWlahgNbrjh1hzVBCNHjyDuehhOw42HRXxvL4E130_assertion type Assertion NP650186.RAikc1HGWlahgNbrjh1hzVBCNHjyDuehhOw42HRXxvL4E130_head.
- NP650186.RAikc1HGWlahgNbrjh1hzVBCNHjyDuehhOw42HRXxvL4E130_assertion description "[We concluded that ECRG2 is a potential molecular target in biological therapy strategies for cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650186.RAikc1HGWlahgNbrjh1hzVBCNHjyDuehhOw42HRXxvL4E130_provenance.
- NP650186.RAikc1HGWlahgNbrjh1hzVBCNHjyDuehhOw42HRXxvL4E130_assertion evidence source_evidence_literature NP650186.RAikc1HGWlahgNbrjh1hzVBCNHjyDuehhOw42HRXxvL4E130_provenance.
- NP650186.RAikc1HGWlahgNbrjh1hzVBCNHjyDuehhOw42HRXxvL4E130_assertion SIO_000772 23079671 NP650186.RAikc1HGWlahgNbrjh1hzVBCNHjyDuehhOw42HRXxvL4E130_provenance.
- NP650186.RAikc1HGWlahgNbrjh1hzVBCNHjyDuehhOw42HRXxvL4E130_assertion wasDerivedFrom befree-20140225 NP650186.RAikc1HGWlahgNbrjh1hzVBCNHjyDuehhOw42HRXxvL4E130_provenance.
- NP650186.RAikc1HGWlahgNbrjh1hzVBCNHjyDuehhOw42HRXxvL4E130_assertion wasGeneratedBy ECO_0000203 NP650186.RAikc1HGWlahgNbrjh1hzVBCNHjyDuehhOw42HRXxvL4E130_provenance.